NCT06810375RecruitingPhase 3
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
Source: ClinicalTrials.gov · Last updated 9 Apr 2026
Brief summary (registry, in English)
This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 24 Jan 2025
- Start date
- 1 Mar 2025
- Primary completion date
- 28 Feb 2028
- Lead sponsor
- George Washington University
- Diseases
- Lung cancer
- NCT number
- NCT06810375
What you commit to
- Study type: Interventional · Phase 3
- Planned participants: 120
- From 1 Mar 2025 to the primary completion date, 28 Feb 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient undergoing bilateral surgery
- Surgery is emergent as deemed by the principal investigator
Other illness
- Allergy to local anesthetics
Who the study is looking for
- Video assisted pulmonary resection, pleurodesis or decortication
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The George Washington University Hospital Coordinator of this site? Confirm its status | Washington D.C. | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.